Friday, February 03, 2017 9:22:33 AM
2017-02-03T12:58:11+00:00
TORONTO, ONTARIO--(Marketwired - Feb. 3, 2017) - Great Lakes Graphite Inc. ("GLK" or the "Company") (TSX VENTURE:GLK)(OTC PINK:GLKIF)(FRANKFURT:8GL) announces today that the Company has received a purchase order for 400 kilograms of micronized natural flake graphite from a large corporation headquartered in Western Europe with two production facilities in North America and a third production facility in the Middle East. The customer was provided with an initial sample of two kilograms of material for qualification testing and is now purchasing a larger quantity to conduct production-scale qualification tests.
The customer manufactures foams and chemicals that are used in a number of industries to make a wide range of products that include range from a wood substitute used in signage to cryogenic applications used in natural gas production processes. In this particular case, the customer is targeting improved performance for a particular set of products, which has been achieved by adding graphite.
Great Lakes Graphite Chief Executive Officer Paul Gorman said, "We are excited to be working with this customer for a number of reasons. The customer represents new markets for us, both geographically and also in terms of the targeted application set. We have been enjoying strong early success with our synthetic graphite products and are now gearing up marketing efforts for our natural flake graphite products. We are continuing to work through our partners to manage the production of these initial orders and are able to do so until such time as we are prepared to initiate and transition manufacturing operations to the Matheson facility."
Mike Coscia, GLK's Sr. Vice President of Sales said, "Product qualifications typically take several months. In this case we sent initial samples just before Christmas and the customer was able to put the material through their initial qualification protocol very quickly. Our sampling program is proving to be an effective means of attracting prospects and serves as an excellent entry point for beginning the conversion process of turning leads into customers."
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM